|
Market Closed -
Bombay S.E.
06:20:11 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 1,006.70 INR | -3.05% |
|
-2.68% | -7.63% |
| 08-06 | Jenburkt Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-13 | Jenburkt Pharmaceuticals Limited Announces Address Changes | CI |
| Market Cap | 4.44B 46.47M 39.96M 37.71M 34.35M 64.21M 64.8M 449M 173M 2.25B 175M 171M 7.16B | P/E 2025 |
13.9x | P/E 2026 | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.99B 41.78M 35.93M 33.9M 30.88M 57.74M 58.26M 404M 155M 2.03B 157M 153M 6.44B | EV / Sales 2025 |
2.82x | EV / Sales 2026 | 2.23x |
| Free-Float |
38.82% | Yield 2025 |
1.78% | Yield 2026 | 2.17% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| JENBURPH | Delayed | |
NSE India S.E.
| JENBURPH | Delayed |
| 1 day | -3.05% | ||
| 1 week | -2.68% | ||
| Current month | -4.15% | ||
| 1 month | -5.48% | ||
| 3 months | -13.04% | ||
| 6 months | +0.66% | ||
| Current year | -7.63% |
| 1 week | 1,000 |  | 1,055.2 |
| 1 month | 1,000 | | 1,088.95 |
| Current year | 944 | | 1,245 |
| 1 year | 944 | | 1,321 |
| 3 years | 586.9 | | 1,410 |
| 5 years | 452 | | 1,410 |
| 10 years | 243.2 | | 1,410 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2013-10-21 | |
| Director of Finance/CFO | 74 | 2013-09-23 | |
Virendra Zope
ADM | Chief Administrative Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2013-10-21 | |
| Director/Board Member | 74 | 2013-09-06 | |
| Director/Board Member | 63 | 2020-03-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.05% | -2.68% | -5.87% | +43.53% | 47.93M | |
| -0.18% | -2.47% | +48.22% | +88.22% | 1,001B | |
| +1.19% | -2.21% | +50.78% | +65.46% | 642B | |
| +1.09% | +0.75% | +17.33% | +73.36% | 451B | |
| -0.03% | -3.31% | +28.61% | +35.96% | 340B | |
| +0.19% | -13.26% | +10.43% | +27.28% | 263B | |
| +0.43% | -1.52% | -1.10% | +12.59% | 247B | |
| -0.93% | -13.20% | +34.23% | +45.01% | 207B | |
| -3.54% | -7.33% | -19.92% | -59.50% | 197B | |
| +0.03% | -4.19% | +22.75% | +87.79% | 180B | |
| Average | -0.49% | -4.99% | +18.55% | +41.97% | 352.64B | |
| Weighted average by Cap. | +0.09% | -4.65% | +30.66% | +56.50% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.52B 15.87M 13.64M 12.87M 11.73M 21.92M 22.12M 153M 59.01M 769M 59.58M 58.28M 2.44B | 1.69B 17.65M 15.18M 14.32M 13.05M 24.39M 24.61M 171M 65.64M 856M 66.28M 64.83M 2.72B |
| Net income | 321M 3.35M 2.88M 2.72M 2.48M 4.63M 4.68M 32.41M 12.47M 163M 12.59M 12.32M 517M | 347M 3.63M 3.12M 2.95M 2.69M 5.02M 5.07M 35.11M 13.51M 176M 13.64M 13.35M 560M |
| Net Debt | -192M -2.01M -1.73M -1.63M -1.49M -2.78M -2.81M -19.46M -7.49M -97.64M -7.56M -7.4M -310M | -448M -4.69M -4.03M -3.8M -3.47M -6.48M -6.54M -45.31M -17.44M -227M -17.61M -17.22M -722M |
Employees
801
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | ₹1,006.70 | -3.05% | 794 |
| 26-09-10 | ₹1,038.40 | +1.43% | 825 |
| 26-09-09 | ₹1,023.80 | -2.98% | 802 |
| 26-09-08 | ₹1,055.20 | +1.46% | 6 |
| 26-09-07 | ₹1,040.00 | +0.54% | 5 |
- Stock Market
- Stocks
- JENBURPH Stock
Select your edition
All financial news and data tailored to specific country editions
